Identification and determination of the urinary metabolite of iodotyrosine in vivo
Open Access
- 20 October 2024
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 735, 150854
Abstract
No abstract availableKeywords
All Related Versions
This publication has 16 references indexed in Scilit:
- Iodotyrosines Are Biomarkers for Preclinical Stages of Iodine-Deficient Hypothyroidism in Dehal1 -Knockout MiceThyroid®, 2023
- Determination of 3-monoiodotyrosine and 3,5-diiodotyrosine in newborn urine and dried urine spots by isotope dilution tandem mass spectrometryThe Analyst, 2022
- The role of endogenous bromotyrosine in health and diseaseFree Radical Research, 2019
- The metabolism and de-bromination of bromotyrosine in vivoFree Radical Biology and Medicine, 2016
- Towards the pre-clinical diagnosis of hypothyroidism caused by iodotyrosine deiodinase (DEHAL1) defectsBest Practice & Research Clinical Endocrinology & Metabolism, 2014
- Genetics and phenomics of hypothyroidism and goiter due to iodotyrosine deiodinase (DEHAL1) gene mutationsMolecular and Cellular Endocrinology, 2010
- Mutations in the Iodotyrosine Deiodinase Gene and HypothyroidismNew England Journal of Medicine, 2008
- The Metabolism and Dechlorination of Chlorotyrosine in VivoJournal of Biological Chemistry, 2007
- Nitration of endogenous para-hydroxyphenylacetic acid and the metabolism of nitrotyrosineBiochemical Journal, 2003
- Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteinsFood and Chemical Toxicology, 1990